Genetic Signatures Ltd - Asset Resilience Ratio

Latest as of December 2025: 60.91%

Genetic Signatures Ltd (GSS) has an Asset Resilience Ratio of 60.91% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Genetic Signatures Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$29.87 Million

≈ $21.13 Million USD Cash + Short-term Investments

Total Assets

AU$49.04 Million

≈ $34.70 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Genetic Signatures Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see GSS current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Genetic Signatures Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Genetic Signatures Ltd total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$17.19 Million	35.05%
Short-term Investments	AU$12.68 Million	25.86%
Total Liquid Assets	AU$29.87 Million	60.91%

Asset Resilience Insights

Very High Liquidity: Genetic Signatures Ltd maintains exceptional liquid asset reserves at 60.91% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Genetic Signatures Ltd Industry Peers by Asset Resilience Ratio

Compare Genetic Signatures Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Hangzhou Tigermed Consulting SHE:300347	Diagnostics & Research	0.11%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Avricore Health Inc V:AVCR	Diagnostics & Research	1.71%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for Genetic Signatures Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Genetic Signatures Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	43.61%	AU$23.82 Million ≈ $16.86 Million	AU$54.63 Million ≈ $38.65 Million	-4.55pp
2024-06-30	48.15%	AU$32.40 Million ≈ $22.93 Million	AU$67.29 Million ≈ $47.61 Million	+27.78pp
2023-06-30	20.38%	AU$10.00 Million ≈ $7.08 Million	AU$49.08 Million ≈ $34.73 Million	-21.53pp
2022-06-30	41.91%	AU$25.00 Million ≈ $17.69 Million	AU$59.65 Million ≈ $42.21 Million	-4.35pp
2021-06-30	46.26%	AU$25.00 Million ≈ $17.69 Million	AU$54.05 Million ≈ $38.24 Million	+16.08pp
2020-06-30	30.17%	AU$15.00 Million ≈ $10.61 Million	AU$49.72 Million ≈ $35.18 Million	-21.86pp
2019-06-30	52.03%	AU$6.31 Million ≈ $4.47 Million	AU$12.13 Million ≈ $8.58 Million	-9.27pp
2018-06-30	61.30%	AU$8.95 Million ≈ $6.34 Million	AU$14.61 Million ≈ $10.34 Million	-13.34pp
2017-06-30	74.64%	AU$13.19 Million ≈ $9.33 Million	AU$17.67 Million ≈ $12.51 Million	--

pp = percentage points

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$12.54 Million

AU$17.72 Million AUD

Market Cap Rank

#26560 Global

#1216 in Australia

Share Price

AU$0.08

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.38

All Time High

AU$2.75